ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
CV Therapeutics (MM)

CV Therapeutics (MM) (CVTX)

20.01
0.00
(0.00%)
Closed March 28 04:00PM
0.00
0.00
(0.00%)

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
20.01
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
20.01
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CVTX Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

CVTX Discussion

View Posts
RedStick RedStick 15 years ago
Nice day today, will we drop and fill the gap?
👍️0
surf1944 surf1944 17 years ago
Hedge fund investor Third Point appears to be high on biopharmaceutical company CV Therapeutics (CVTX - Cramer's Take - Stockpickr - Rating).

Third Point, run by manager Daniel Loeb, piled about $51 million into the Palo Alto, Calif.-based drug company. Over the last two months it bought 5.9 million shares, representing a nearly 10% stake in CV Therapeutics.

An external spokesman for Third Point declined to comment. A CV Therapeutics spokesman declined to comment.

The small drug company, which makes drugs for treating heart disease, said last month that first-quarter sales of heart drug Ranexa rose 33% from fourth-quarter levels to $12 million. The company, which lost $55 million in the quarter ended March 31, received U.S. approval for the drug back in January 2006.

Although Ranexa is the company's only approved drug at this point, CV Therapeutics said this week it has submitted a new drug application to the Food and Drug Administration seeking to use regadenoson in myocardial perfusion imaging studies. The filing triggered a milestone payment by partner Astellas.

"We are very pleased to have submitted an NDA for regadenoson, which, if approved in 2008, would represent the second innovative cardiovascular product CV Therapeutics will have brought to market in a two-year period," said CV Therapeutics CEO Louis G. Lange in statement Monday.

CV Therapeutics, which has a market capitalization of about $670 million, rose more than 6% in regular trading Thursday to $11.28 before giving back some ground in after-hours action.
👍️0
surf1944 surf1944 17 years ago
First Albany Capital said the upgrade of the biopharmaceutical company's stock is based on better-than-expected sales of angina drug Ranexa, sooner-than-expected publication of the MERLIN trial results, and planned reductions of operating expenses.

--The brokerage's new price target on the stock is $13. (Reporting by Ratul Ray Chaudhuri in Bangalore)
👍️0
surf1944 surf1944 17 years ago
There is still another shoe to drop, but not sure which way it will go.
👍️0
Cashoutfl Cashoutfl 17 years ago
Good Info. Wish I had seen this last week, I'll watch it closely now.
👍️0
surf1944 surf1944 17 years ago
Tomorrow the PIII trial news will be out before the bell(one anal-list says Sell w/ $2 PPS target & the other one says Buy w/ $40 PPS target) Could be fireworks in the morning..........

👍️0
Bull Trader Bull Trader 17 years ago
surf - your always on top of your game - creating new boards. Nice possible bouncer here? Good work bro. BLUE
👍️0
surf1944 surf1944 17 years ago
News will be coming out of the ACC meeting in New Orleans over the weekend(may be a big mover next week... up or down)
👍️0

Your Recent History

Delayed Upgrade Clock